Glassman Wealth Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
MG
AI
Glassman Wealth Services's CRL Position: Q1 2024 in Review
Glassman Wealth Services sold out of Charles River Laboratories (CRL) in Q1 2024, closing a stake of 48 shares — an estimated $11.3K sold.
Glassman Wealth Services first reported a position in CRL in Q1 2018 and held it in 24 quarters. The position peaked at $50.1K in Q4 2022. 676 funds tracked by Wall St. Rank hold CRL as of Q1 2024.
- Glassman Wealth Services reported no remaining Charles River Laboratories position as of Q1 2024 after selling out during the quarter.
- Glassman Wealth Services sold 48 Charles River Laboratories shares in Q1 2024, an estimated $11.3K.
- Glassman Wealth Services first reported a position in Charles River Laboratories in Q1 2018 and held it in 24 quarters.
- Glassman Wealth Services's Charles River Laboratories position peaked at $50.1K in Q4 2022.
- 676 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2024.
Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.